European Society of Cardiology
Skip navigation links
Home
About the ESC
Membership
Communities
Congresses
Education
Guidelines & Surveys
Journals
Initiatives
Welcome to the European Society of Cardiology. Our mission: to reduce the burden of cardiovascular disease in Europe
 

Cardiovascular Pharmacology and Drug Therapy

Promoting research, teaching and clinical activities

WG Pharmacology logo
ESC Working Group Cardiovascular Pharmacology and Drug Therapy Chair Ruilope
The ESC Working Group on Cardiovascular Pharmacology and Drug Therapy aims to promote research, teaching and clinical activity, as well as advising the ESC Board on matters relating to Cardiovascular Pharmacology and Drug Therapy.

One particular focus of our Working Group is "trials science", i.e., the discipline dealing with the planning, conduct and evaluation of evidence gained through cardiovascular trials.

The Working Group contributes actively to the organisation of the ESC Congress and the generation of the ESC Guidelines.The dedicated congress of the Working Group (as co-organiser) is the "Global-CVCT" (Cardiovascular Clinical Trialists Forum"), which takes place in Cannes every December. It aims at bringing together Cardiologists, Academia, Industry and Regulatory Authorities for in-depth discussion of trials science.

Prof. Luis Miguel RUILOPE, FESC
Chairman 2010-2012

 QUICK ACCESS

 

 

8th CVCT
 1-3 December 2011 Paris, France
Report on CVCT 2010

Apply now and get automatic membership to ESC

Latest FCP scientific articles authored by the Working Group

 
Anaemia in heart failure: intravenous iron therapy

Intravenous iron has emerged as a well tolerated and effective therapy to improve symptoms and quality of life in both anaemic and non-anaemic heart failure patients with iron deficiency...(An article from the E-Journal of the ESC Council for Cardiology Practice)

Read More